J Gastric Cancer.  2010 Dec;10(4):219-225.

Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer

Affiliations
  • 1Department of Surgery, Postgraduate School of Medicine, Pusan National University, Busan, Korea. kdhun@pusan.ac.kr
  • 2Department of Internal Medicine, Postgraduate School of Medicine, Pusan National University, Busan, Korea.
  • 3Department of Pathology, Postgraduate School of Medicine, Pusan National University, Busan, Korea.

Abstract

PURPOSE
The long-term survival rate of gastric cancer patients after surgery has recently increased as a result of making an early diagnosis of gastric cancer. Therefore, the incidence of remnant gastric cancer is increasing. This study was performed to evaluate the clinicopathological characteristics and prognosis of patients with remnant gastric cancer.
MATERIALS AND METHODS
From January 2005 to December 2009, twenty-nine patients with remnant gastric cancer and who underwent surgery at Pusan National University Hospital were enrolled in this study. We retrospectively reviewed and analyzed their medical records. We also divided them into two groups: the remnant gastric cancer (RGC)-B group (first operation for benign disease) and the RGC-M group (first operation for malignant disease).
RESULTS
The RGC-B group included ten patients and the RGC-M group included nineteen patients. The mean interval between the first and second operations was 17 years. The curative resection rate was 93.1% (27/29). The postoperative complication rate was 20.7% (6/29) and there was no perioperative mortality. Ten (37%) of twenty-seven patients experienced recurrence after curative resection and eight patients (27.6%) expired due to aggravation of remnant stomach cancer. An advanced TNM stage and non-curative resection were the negative prognostic factors for survival for patients with remnant stomach cancer (P=0.0453 and P<0.001). The RGC-M group showed a shorter interval (P<0.001) and the RGC-B group had more advanced TNM stage (P=0.003).
CONCLUSIONS
Long-term follow-up should be considered not only for patients who undergo an operation for malignant disease, but also for the patients who underwent an operation for benign disease. When remnant gastric cancer is diagnosed, curative resection is essential to improve the survival.

Keyword

Gastric remnant cancer; Prognosis; Survival

MeSH Terms

Early Diagnosis
Gastric Stump
Humans
Incidence
Medical Records
Postoperative Complications
Prognosis
Recurrence
Retrospective Studies
Stomach Neoplasms
Survival Rate

Reference

1. Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg. 2007. 94:92–95.
Article
2. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg. 1996. 182:1–6.
3. Kaneko K, Kondo H, Saito D, Shirao K, Yamaguchi H, Yokota T, et al. Early gastric stump cancer following distal gastrectomy. Gut. 1998. 43:342–344.
Article
4. Firat O, Guler A, Sozbilen M, Ersin S, Kaplan H. Gastric remnant cancer: an old problem with novel concerns. Langenbecks Arch Surg. 2009. 394:93–97.
Article
5. Hu X, Tian DY, Cao L, Yu Y. Progression and prognosis of gastric stump cancer. J Surg Oncol. 2009. 100:472–476.
Article
6. Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol. 2008. 15:1632–1639.
Article
7. Thorban S, Böttcher K, Etter M, Roder JD, Busch R, Siewert JR. Prognostic factors in gastric stump carcinoma. Ann Surg. 2000. 231:188–194.
Article
8. Lissens P, Filez L, Aerts R, D'Hoore A, Van Cutsem E, Ectors N, et al. Surgery for gastric remnant carcinoma following Billroth II gastrectomy. Eur J Surg Oncol. 1997. 23:518–521.
Article
9. An JY, Youn HG, Ha TK, Choi MG, Kim KM, Noh JH, et al. Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer. J Gastrointest Surg. 2008. 12:689–694.
Article
10. Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma - epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007. 33:133–139.
Article
11. Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg. 1993. 80:54–56.
Article
12. Kaminishi M, Shimizu N, Yamaguchi H, Hashimoto M, Sakai S, Oohara T. Different carcinogenesis in the gastric remnant after gastrectomy for gastric cancer. Cancer. 1996. 77:8 Suppl. 1646–1653.
Article
13. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002. 5:177–182.
Article
14. Zhang Y, Tokunaga A, Masuda G, Okuda T, Kiyama T, Yoshiyuki T, et al. Surgical treatment of gastric remnant-stump cancer. J Nippon Med Sch. 2002. 69:489–493.
Article
15. Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, et al. Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy. J Gastrointest Surg. 2010. 14:277–281.
Article
Full Text Links
  • JGC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr